Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu
Shaping the Future: Wilmot Equips the Next Generation of Oncologists and Scientists

Shaping the Future: Wilmot Equips the Next Generation of Oncologists and Scientists

As part of an academic medical center, Wilmot Cancer Institute has a responsibility to develop the next generation of physicians and researchers and to help shape the ever-evolving landscape of science and medicine. 

Does Chemo Brain Go Away? Wilmot Scientists Investigate

Does Chemo Brain Go Away? Wilmot Scientists Investigate

Wilmot Cancer Institute scientists have already discovered that “chemo brain” is a substantial problem that can linger for six months after chemotherapy ends. A new, $3 million grant ensures the research will continue — with the next questions focusing on whether the cognitive decline can continue for up to 10 years and how best to treat it.

Wilmot Receives $29M NCORP Grant: A Q&A with Gary Morrow

Wilmot Receives $29M NCORP Grant: A Q&A with Gary Morrow

Cancer Control research focuses on making life better for cancer patients. Now, as a patient himself, Researcher Gary Morrow, Ph.D., MS., says he’s been able to experience the science he helped to sow.

Investigators Looking to a Better Future for Patients with Bladder Cancer 

Investigators Looking to a Better Future for Patients with Bladder Cancer 

Wilmot researchers are revealing new insights into what drives the disease and possible new treatment pathways. 

Lymphoma: Looking for Clues in the Immune System

Lymphoma: Looking for Clues in the Immune System

Wilmot researchers are studying the non-cancer cells in a tumor — known as the tumor microenvironment — to learn more about the important role they play in the course of lymphoma.